Benedikt R.
- Country
- Norway
- Department
- ..
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Oncology
The investigator engages in clinical studies addressing solid tumours and haematologic malignancies.
- Triple‑negative breast cancer
- HER2‑positive breast cancer
- Non‑small cell lung cancer
- Multiple myeloma
- Acute myeloid leukaemia
Efforts span early‑stage and advanced disease settings.
Neurology
Focus includes neurodegenerative and cerebrovascular conditions such as Alzheimer's disease and Acute Ischemic Stroke.
- Acute Ischemic Stroke
- Multiple sclerosis
- Amyotrophic Lateral Sclerosis
- Alzheimer's disease
- Dementia with Lewy Bodies
Research targets disease progression and functional outcomes.
Cardiovascular Medicine
Clinical work covers acute coronary events and arrhythmia‑related stroke prevention, including Acute myocardial infarction and Atrial fibrillation.
- Acute myocardial infarction
- Atrial fibrillation
- Hypertension
- Chronic Heart Failure
- Cardiovascular disease
Studies evaluate both acute interventions and long‑term risk management.
Autoimmune & Immunology
Involvement in disorders characterised by immune dysregulation such as Rheumatoid arthritis and Systemic Lupus Erythematosus.
- Rheumatoid arthritis
- Systemic Lupus Erythematosus
- Immune Thrombocytopenia
- Sjogren's syndrome
- Hidradenitis suppurativa
Therapeutic strategies include biologics and targeted small molecules.
Metabolic & Renal Diseases
Research includes metabolic disorders and kidney disease, exemplified by Type 2 diabetes and Chronic Kidney Disease.
- Type 2 diabetes
- Obesity
- Chronic Kidney Disease
- Proteinuric kidney disease
- Metabolic control in antipsychotic‑using patients
Aim is to improve glycaemic control and renal outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.